Treatment decision for cancer patients with fever during the coronavirus disease 2019 (COVID-19) pandemic
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Cancer patients have been disproportionally affected by the coronavirus disease 2019 (COVID-19) pandemic, with high rates of severe outcomes and mortality. Fever is the most common symptom in COVID-19 patients. During the COVID-19 pandemic, physicians may have difficulty in determining the cause of fever (COVID-19, another infection, or cancer fever) in cancer patients. Furthermore, there are no specific guidelines for managing cancer patients with fever during the COVID-19 pandemic. Thus, this study evaluated the clinical characteristics and outcomes of cancer patients with fever during the COVID-19 pandemic. Methods: This study retrospectively reviewed the medical records of 328 cancer patients with COVID-19 symptoms (fever) admitted to five hospitals in Daegu, Korea from January to October 2020. We obtained data on demographics, clinical manifestations, laboratory test results, chest computed tomography images, cancer history, cancer treatment, and outcomes of all enrolled patients from electronic medical records. Results: The most common COVID-19-like symptoms were fever (n=256, 78%). Among 256 patients with fever, only three (1.2%) were diagnosed with COVID-19. Most patients (253, 98.8%) with fever were not diagnosed with COVID-19. The most common solid malignancies were lung cancer (65, 19.8%) and hepatobiliary cancer (61, 18.6%). Twenty patients with fever experienced a delay in receiving cancer treatment. Eighteen patients discontinued active cancer treatment because of fever. Major events during the treatment delay period included death (2.7%), cancer progression (1.5%), and major organ dysfunction (2.7%). Conclusion: Considering that only 0.9% of patients tested for COVID-19 were positive, screening for COVID-19 in cancer patients with fever should be based on the physician’s clinical decision, and patients might not be routinely tested.
Abstract
Background: Cancer patients have been disproportionally affected by the coronavirus disease 2019 (COVID-19) pandemic, with high rates of severe outcomes and mortality. Fever is the most common symptom in COVID-19 patients. During the COVID-19 pandemic, physicians may have difficulty in determining the cause of fever (COVID-19, another infection, or cancer fever) in cancer patients. Furthermore, there are no specific guidelines for managing cancer patients with fever during the COVID-19 pandemic. Thus, this study evaluated the clinical characteristics and outcomes of cancer patients with fever during the COVID-19 pandemic. Methods: This study retrospectively reviewed the medical records of 328 cancer patients with COVID-19 symptoms (fever) admitted to five hospitals in Daegu, Korea from January to October 2020. We obtained data on demographics, clinical manifestations, laboratory test results, chest computed tomography images, cancer history, cancer treatment, and outcomes of all enrolled patients from electronic medical records. Results: The most common COVID-19-like symptoms were fever (n=256, 78%). Among 256 patients with fever, only three (1.2%) were diagnosed with COVID-19. Most patients (253, 98.8%) with fever were not diagnosed with COVID-19. The most common solid malignancies were lung cancer (65, 19.8%) and hepatobiliary cancer (61, 18.6%). Twenty patients with fever experienced a delay in receiving cancer treatment. Eighteen patients discontinued active cancer treatment because of fever. Major events during the treatment delay period included death (2.7%), cancer progression (1.5%), and major organ dysfunction (2.7%). Conclusion: Considering that only 0.9% of patients tested for COVID-19 were positive, screening for COVID-19 in cancer patients with fever should be based on the physician’s clinical decision, and patients might not be routinely tested.
참고문헌 (19)
- Zhang L, "Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China", Ann Oncol, 31, pp.894~901 (2020)
- Kuderer NM, "Clinical impact of COVID-19 on patients with cancer(CCC19) : a cohort study", Lancet, 395, pp.1907~1918 (2020)
- Liang W, "Cancer patients in SARS-CoV-2 infection : a nationwide analysis in China", Lancet Oncol, 21, pp.335~337 (2020)
- Onder G, "Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy", JAMA, 323, pp.1775~1776 (2020)
- Zhao D, "A comparative study on the clinical features of coronavirus 2019(COVID-19)pneumonia with other pneumonias", Clin Infect Dis, 71, pp.756~761 (2020)
- Zhu J, "Clinical characteristics of 3062 COVID-19 patients : a meta-analysis", J Med Virol, 92, pp.1902~1914 (2020)
- Wiersinga WJ, "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review", JAMA, 324, pp.782~793 (2020)
- Yang J, "Prevalence of comorbidities and its effects in patients infected with SARSCoV-2 : a systematic review and meta-analysis", Int J Infect Dis, 94, pp.91~95 (2020)
- Rodriguez-Morales AJ, "Clinical, laboratory and imaging features of COVID-19:a systematic review and meta-analysis", Travel Med Infect Dis, 34, pp.101623~ (2020)
- Foggo V, "Malignant causes of fever of unknown origin", Clin Med(Lond), 15, pp.292~294 (2015)
- Schneider A, "Covid-19 in outpatients : is fever a useful indicator for SARS-CoV-2 infection", PLoS One, 16, pp.e0246312~ (2021)
- Islam KU, "An update on molecular diagnostics for COVID-19", Front Cell Infect Microbiol, 10, pp.560616~ (2020)
- Seyed Hosseini E, "The novel coronavirus Disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies", Virology, 551, pp.1~9 (2020)
- Yüce M, "COVID-19 diagnosis : a review of current methods", Biosens Bioelectron, 172, pp.112752~ (2021)
- Marc Boutros, "Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea", Critical Reviews in Oncology, 2021, pp.167, 103273~[DOI]
- Hanna TP, "Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic", Nat Rev Clin Oncol, 17, pp.268~270 (2020)
- Jee J, "Chemotherapy and COVID-19 outcomes in patients with cancer", J Clin Oncol, 38, pp.3538~3546 (2020)
- Pasikhova Y, "Fever in patients with cancer", Cancer Control, 24, pp.193~197 (2017)
- 이기쁨, "Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea", Cancer Research and Treatment, 53(2), pp.323~329 (2021), 대한암학회[DOI]